Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 165
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Casaletto, Kaitlin B. Moore, David J. Woods, Steven Paul Umlauf, Anya Scott, J. C. and Heaton, Robert K. 2016. Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users. The Clinical Neuropsychologist, Vol. 30, Issue. 1, p. 107.


    Cody, Shameka L. and Vance, David E. 2016. The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population. Neurobiology of Disease, Vol. 92, p. 144.


    Evering, Teresa H. Applebaum, Allison La Mar, Melissa Garmon, Donald Dorfman, David and Markowitz, Martin 2016. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection. AIDS, Vol. 30, Issue. 2, p. 203.


    Marquine, M. J. Sakamoto, M. Dufour, C. Rooney, A. Fazeli, P. Umlauf, A. Gouaux, B. Franklin, D. Ellis, R. Letendre, S. Cherner, M. Heaton, R. K. Grant, I. and Moore, D. J. 2016. The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons. Journal of NeuroVirology, Vol. 22, Issue. 4, p. 442.


    Marquine, María J. Montoya, Jessica L. Umlauf, Anya Fazeli, Pariya L. Gouaux, Ben Heaton, Robert K. Ellis, Ronald J. Letendre, Scott L. Grant, Igor and Moore, David J. 2016. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clinical Infectious Diseases, p. ciw328.


    Montoya, Jessica L. Cattie, Jordan Morgan, Erin Woods, Steven Paul Cherner, Mariana Moore, David J. Atkinson, J. Hampton Grant, Igor and Translational Methamphetamine AIDS, The 2016. The impact of age, HIV serostatus and seroconversion on methamphetamine use. The American Journal of Drug and Alcohol Abuse, Vol. 42, Issue. 2, p. 168.


    Morgan, Erin E. Iudicello, Jennifer E. Weber, Erica and Woods, Steven Paul 2016. Neuropathology of Drug Addictions and Substance Misuse.


    Sagar, Vidya Atluri, Venkata Subba Rao Pilakka-Kanthikeel, Sudheesh and Nair, Madhavan 2016. Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse. Molecular Brain, Vol. 9, Issue. 1,


    Shuper, Paul A. Joharchi, Narges Irving, Hyacinth Fletcher, David Kovacs, Colin Loutfy, Mona Walmsley, Sharon L. Wong, David K.H. and Rehm, Jürgen 2016. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals. AIDS Care, Vol. 28, Issue. 8, p. 954.


    Soontornniyomkij, Virawudh Umlauf, Anya Soontornniyomkij, Benchawanna Batki, Isabella B. Moore, David J. Masliah, Eliezer and Achim, Cristian L. 2016. Lifetime methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults. Journal of NeuroVirology,


    Borgmann, Kathleen and Ghorpade, Anuja 2015. HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Frontiers in Microbiology, Vol. 6,


    Casaletto, K.B. Obermeit, L. Morgan, E.E. Weber, E. Franklin, D.R. Grant, I. and Woods, S.P. 2015. Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders. Addictive Behaviors, Vol. 40, p. 45.


    Cattie, Jordan Marquine, Maria J. Bolden, Khalima A. Obermeit, Lisa C. Morgan, Erin E. Franklin, Donald R. Umlauf, Anya Beck, Jennifer M. Hampton Atkinson, J. Grant, Igor and Woods, Steven P. 2015. Predictors of attrition in a cohort study of HIV infection and methamphetamine dependence. Journal of Substance Use, Vol. 20, Issue. 6, p. 407.


    Crane, Natania A. Schuster, Randi Melissa Mermelstein, Robin J. and Gonzalez, Raul 2015. Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. Journal of Clinical and Experimental Neuropsychology, Vol. 37, Issue. 4, p. 389.


    Fogel, Gary B. Lamers, Susanna L. Levine, Andrew J. Valdes-Sueiras, Miguel McGrath, Michael S. Shapshak, Paul and Singer, Elyse J. 2015. Factors related to HIV-associated neurocognitive impairment differ with age. Journal of NeuroVirology, Vol. 21, Issue. 1, p. 56.


    Gonzalez, Raul Schuster, Randi M. Mermelstein, Robin M. and Diviak, Kathleen R. 2015. The role of decision-making in cannabis-related problems among young adults. Drug and Alcohol Dependence, Vol. 154, p. 214.


    Hoefer, Melanie M. Sanchez, Ana B. Maung, Ricky de Rozieres, Cyrus M. Catalan, Irene C. Dowling, Cari C. Thaney, Victoria E. Piña-Crespo, Juan Zhang, Dongxian Roberts, Amanda J. and Kaul, Marcus 2015. Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system. Experimental Neurology, Vol. 263, p. 221.


    Kesby, James P. Markou, Athina and Semenova, Svetlana 2015. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice. European Neuropsychopharmacology, Vol. 25, Issue. 1, p. 141.


    Kesby, James P Heaton, Robert K Young, Jared W Umlauf, Anya Woods, Steven P Letendre, Scott L Markou, Athina Grant, Igor and Semenova, Svetlana 2015. Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice. Neuropsychopharmacology, Vol. 40, Issue. 8, p. 1899.


    Kore, Idil Ananworanich, Jintanat Valcour, Victor Fletcher, James L. K. Chalermchai, Thep Paul, Robert Reynolds, Jesse Tipsuk, Somporn Ubolyam, Sasiwimol Rattanamanee, Somprartthana Jagodzinski, Linda Kim, Jerome and Spudich, Serena 2015. Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 70, Issue. 4, p. 393.


    ×
  • Journal of the International Neuropsychological Society, Volume 10, Issue 1
  • January 2004, pp. 1-14

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

  • JULIE D. RIPPETH (a1), ROBERT K. HEATON (a1) (a2), CATHERINE L. CAREY (a2), THOMAS D. MARCOTTE (a1) (a2), DAVID J. MOORE (a2), RAUL GONZALEZ (a2), TANYA WOLFSON (a1), IGOR GRANT (a1) (a2) (a3) and THE HNRC GROUP (a1)
  • DOI: http://dx.doi.org/10.1017/S1355617704101021
  • Published online: 01 February 2004
Abstract

Both HIV infection and methamphetamine dependence can be associated with brain dysfunction. Little is known, however, about the cognitive effects of concurrent HIV infection and methamphetamine dependence. The present study included 200 participants in 4 groups: HIV infected/methamphetamine dependent (HIV+/METH+), HIV negative/methamphetamine dependent (HIV−/METH+), HIV infected/methamphetamine nondependent (HIV+/METH−), and HIV negative/methamphetamine nondependent (HIV−/METH−). Study groups were comparable for age, education, and ethnicity, although the HIV−/METH− group had significantly more females. A comprehensive, demographically corrected neuropsychological battery was administered yielding a global performance score and scores for seven neurobehavioral domains. Rates of neuropsychological impairment were determined by cutoff scores derived from performances of a separate control group and validated with larger samples of HIV+ and HIV− participants from an independent cohort. Rates of global neuropsychological impairment were higher in the HIV+/METH+ (58%), HIV−/METH+ (40%) and HIV+/METH− (38%) groups compared to the HIV−/METH− (18%) group. Nonparametric analyses revealed a significant monotonic trend for global cognitive status across groups, with least impairment in the control group and highest prevalence of impairment in the group with concurrent HIV infection and methamphetamine dependence. The results indicate that HIV infection and methamphetamine dependence are each associated with neuropsychological deficits, and suggest that these factors in combination are associated with additive deleterious cognitive effects. This additivity may reflect common pathways to neural injury involving both cytotoxic and apoptotic mechanisms. (JINS, 2004, 10, 1–14.)Note: Dr. Erin D. Bigler served as action editor during the course of this review.

Copyright
Corresponding author
Reprint requests to: Igor Grant, MD, HIV Neurobehavioral Research Center, 150 West Washington Street, 2nd Floor, San Diego, CA 92103.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the International Neuropsychological Society
  • ISSN: 1355-6177
  • EISSN: 1469-7661
  • URL: /core/journals/journal-of-the-international-neuropsychological-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: